文献速递心脏核医学

重复心脏磁共振与FDG PET/CT在初始可能心脏结节病诊断中的价值

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis.
PubMed 文献 · EJNMMI Res · 2021-12-20

本研究为回顾性队列研究,纳入35例经多学科团队诊断为可能心脏结节病的患者,在诊断后12个月内重复进行心脏磁共振(CMR)和氟脱氧葡萄糖正电子发射断层扫描(FDG PET/CT)。再评估后9例(25.7%)重新分类为 probable 心脏结节病,16例(45.7%)为 unlikely;重复CMR和FDG PET/CT可能有助于确立或排除心脏结节病诊断,但临床相关性有待进一步确定。

要点

  • 再评估后9例(25.7%)重新分类为 probable 心脏结节病,16例(45.7%)为 unlikely。
  • 基线时11例(31.4%)CMR显示晚期钆增强(CMR+),26例(74.3%)心肌FDG摄取(PET+)。
  • 再评估时9例(25.7%)显示晚期钆增强,16例(45.7%)心肌FDG摄取。

核心结论

  • 当初始诊断不确定时,重复CMR和FDG PET/CT可能有助于确立或排除心脏结节病诊断,但临床相关性有待进一步确定。

研究设计与样本

  • 回顾性队列研究,纳入35例经多学科团队诊断为可能心脏结节病并在诊断后12个月内接受重复CMR和FDG PET/CT的患者。

主要发现

  • 再评估后9例(25.7%)重新分类为 probable 心脏结节病,16例(45.7%)重新分类为 unlikely 心脏结节病。
  • 再评估后2例患者开始免疫抑制治疗。
  • 基线时11例(31.4%)CMR显示晚期钆增强(CMR+),26例(74.3%)显示心肌FDG摄取(PET+)。
  • 再评估时9例(25.7%)显示晚期钆增强(CMR+),16例(45.7%)显示心肌FDG摄取(PET+)。
  • 基线CMR-/PET+的患者中82.6%再评估时重新分类为 possible 或 unlikely 心脏结节病,基线CMR+的患者中36.4%重新分类为 probable 心脏结节病。

关键数值与推荐

  • 心脏结节病诊断分类为 definite、probable、possible 或 unlikely。
  • 影像学模式分类为CMR+/PET+、CMR+/PET-、CMR-/PET+和CMR-/PET-。
  • 主要终点为多学科团队最终心脏结节病诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 临床相关性有待进一步确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET/CT) for CS diagnosis in patients with an initial "possible" CS diagnosis. METHODS: We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET/CT within 12 months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+/PET+, CMR+/PET-, CMR-/PET+ and CMR-/PET-. Primary endpoint was final MDT diagnosis of CS. RESULTS: After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR-/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR-/PET+ showed LGE at re-evaluation. CONCLUSION: Repeated CMR and FDG PET/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Mathijssen H, Tjoeng TWH, Keijsers RGM, et al. The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis. EJNMMI Res. 2021. PMID: 34928457. doi:10.1186/s13550-021-00870-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。